+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bepridil"

Calcium Channel Blocker Market Report 2025 - Product Thumbnail Image

Calcium Channel Blocker Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Bepridil is a cardiovascular drug used to treat angina, a type of chest pain caused by reduced blood flow to the heart. It is a calcium channel blocker, meaning it works by blocking the flow of calcium into the cells of the heart and blood vessels, which helps to reduce the force of heart contractions and relax the blood vessels. Bepridil is available in both oral and intravenous forms, and is typically used in combination with other medications. Bepridil is a relatively uncommon drug, and is not widely used in the United States. It is more commonly used in Europe, where it is approved for use in some countries. It is also used in some parts of Asia and Africa. The market for Bepridil is relatively small, and is dominated by a few major pharmaceutical companies. Some of the companies in the market include Pfizer, Merck, Sanofi, and Novartis. Show Less Read more